Literature DB >> 17519949

Mitochondrial medicine: pharmacological targeting of mitochondria in disease.

J S Armstrong1.   

Abstract

Mitochondria play a central role in cell life and death and are known to be important in a wide range of diseases including the cancer, diabetes, cardiovascular disease, and the age-related neurodegenerative diseases. The unique structural and functional characteristics of mitochondria enable the selective targeting of drugs designed to modulate the function of this organelle for therapeutic gain. This review discusses mitochondrial drug targeting strategies and a variety of novel mitochondrial drug targets including the electron transport chain, mitochondrial permeability transition, Bcl-2 family proteins and mitochondrial DNA. Mitochondrial drug-targeting strategies will open up avenues for manipulating mitochondrial functions and allow for selective protection or eradication of cells for therapeutic gain in a variety of diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519949      PMCID: PMC2189819          DOI: 10.1038/sj.bjp.0707288

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  127 in total

1.  The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides.

Authors:  E J Ackermann; J K Taylor; R Narayana; C F Bennett
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

2.  Mitochondriotropic liposomes.

Authors:  Sarathi V Boddapati; Pakamas Tongcharoensirikul; Robert N Hanson; Gerard G M D'Souza; Vladimir P Torchilin; Volkmar Weissig
Journal:  J Liposome Res       Date:  2005       Impact factor: 3.648

Review 3.  Liposomes and liposome-like vesicles for drug and DNA delivery to mitochondria.

Authors:  Volkmar Weissig; Sarathi V Boddapati; Shing-Ming Cheng; Gerard G M D'Souza
Journal:  J Liposome Res       Date:  2006       Impact factor: 3.648

4.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

5.  Superoxide activates mitochondrial uncoupling proteins.

Authors:  Karim S Echtay; Damien Roussel; Julie St-Pierre; Mika B Jekabsons; Susana Cadenas; Jeff A Stuart; James A Harper; Stephen J Roebuck; Alastair Morrison; Susan Pickering; John C Clapham; Martin D Brand
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

6.  Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.

Authors:  S R Jolly; W J Kane; M B Bailie; G D Abrams; B R Lucchesi
Journal:  Circ Res       Date:  1984-03       Impact factor: 17.367

7.  MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.

Authors:  K Koya; Y Li; H Wang; T Ukai; N Tatsuta; M Kawakami; L B Chen
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

8.  Multiple Q-cycle bypass reactions at the Qo site of the cytochrome bc1 complex.

Authors:  Florian Muller; Antony R Crofts; David M Kramer
Journal:  Biochemistry       Date:  2002-06-25       Impact factor: 3.162

9.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.

Authors:  Matthias L Jauslin; Thomas Meier; Robin A J Smith; Michael P Murphy
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

View more
  59 in total

1.  Carnosic Acid Suppresses the H2O2-Induced Mitochondria-Related Bioenergetics Disturbances and Redox Impairment in SH-SY5Y Cells: Role for Nrf2.

Authors:  Marcos Roberto de Oliveira; Gustavo da Costa Ferreira; Alessandra Peres; Simone Morelo Dal Bosco
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Danthron triggers ROS and mitochondria-mediated apoptotic death in C6 rat glioma cells through caspase cascades, apoptosis-inducing factor and endonuclease G multiple signaling.

Authors:  Shang-Ming Chiou; Chiz-Hao Chiu; Su-Tso Yang; Jai-Sing Yang; Hui-Ying Huang; Chao-Lin Kuo; Po-Yuan Chen; Jing-Gung Chung
Journal:  Neurochem Res       Date:  2012-05-17       Impact factor: 3.996

Review 3.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

4.  Protective effects of asiatic acid on rotenone- or H2O2-induced injury in SH-SY5Y cells.

Authors:  Yuyun Xiong; Hongqun Ding; Minfang Xu; Jing Gao
Journal:  Neurochem Res       Date:  2008-09-19       Impact factor: 3.996

5.  Asiatic acid, a pentacyclic triterpene in Centella asiatica, attenuates glutamate-induced cognitive deficits in mice and apoptosis in SH-SY5Y cells.

Authors:  Min-fang Xu; Yu-yun Xiong; Jian-kang Liu; Jin-jun Qian; Li Zhu; Jing Gao
Journal:  Acta Pharmacol Sin       Date:  2012-03-26       Impact factor: 6.150

Review 6.  Prospects for therapeutic mitochondrial transplantation.

Authors:  Jenna L Gollihue; Alexander G Rabchevsky
Journal:  Mitochondrion       Date:  2017-05-19       Impact factor: 4.160

Review 7.  The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Susanna De Pascalis; Antonio Muscari
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

Review 8.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

Review 9.  Targeted delivery of radioprotective agents to mitochondria.

Authors:  Irina Zabbarova; Anthony Kanai
Journal:  Mol Interv       Date:  2008-12

10.  High-throughput screening of FDA-approved drugs using oxygen biosensor plates reveals secondary mitofunctional effects.

Authors:  Sunil Sahdeo; Alexey Tomilov; Kelly Komachi; Christine Iwahashi; Sandipan Datta; Owen Hughes; Paul Hagerman; Gino Cortopassi
Journal:  Mitochondrion       Date:  2014-07-14       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.